{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:11:59Z","timestamp":1782274319260,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Commission","doi-asserted-by":"crossref","award":["21ZR1479100."],"award-info":[{"award-number":["21ZR1479100."]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Fourth People's Hospital Research Initiation Grant","award":["sykyqd11001"],"award-info":[{"award-number":["sykyqd11001"]}]},{"name":"the Shanghai Key Laboratory of Cell Engineering","award":["14DZ2272300"],"award-info":[{"award-number":["14DZ2272300"]}]},{"name":"Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai, the grants from National Natural Science Foundation of China","award":["No. 82273317"],"award-info":[{"award-number":["No. 82273317"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Acral melanoma (AM) is the predominant subtype of melanoma in Asians. Early detection and prevention can significantly improve patient outcomes; however, there is a lack of effective early biomarkers for predicting AM metastasis. Here, we employed single-cell and spatial transcriptomics analyses to investigate early microsatellite lesions of AM and identify biomarkers of invasiveness in these lesions. Our results characterize a highly immunosuppressive microenvironment and metabolic process shifts in early AM microsatellite lesions that promote the metastatic potential. The transcription factor SOX6 is overexpressed in microsatellite lesions and marks a population of highly invasive melanoma cells. The pro-invasive role of overexpressed SOX6 was validated in vivo and in vitro, including its ability to enhance tumor invasion by upregulating cellular glycolysis, disrupt fatty acid transport, and increase intracellular phosphatidylcholine content. This study suggests that SOX6-overexpressing melanoma cells are the main driver subpopulation promoting early invasion of AM and establishes SOX6 and fatty acid transport processes as biomarkers and potential therapeutic targets for early melanoma metastasis.<\/jats:p>","DOI":"10.1186\/s13046-025-03516-2","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T03:49:16Z","timestamp":1756266556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel SOX6\u2009+\u2009melanoma cell subtype promotes early microsatellite invasion in Asian acral melanoma through fatty acid transport disorder"],"prefix":"10.1186","volume":"44","author":[{"given":"Chuan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"3516_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41420-023-01678-6","volume":"9","author":"K Shen","year":"2023","unstructured":"Shen K, et al. Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score. Cell Death Discovery. 2023;9:397. https:\/\/doi.org\/10.1038\/s41420-023-01678-6","journal-title":"Cell Death Discovery"},{"key":"3516_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"3516_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ccell.2024.04.012","volume":"42","author":"H Liu","year":"2024","unstructured":"Liu H, et al. Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of <\u2009em\u2009>\u2009in situ\u2009and invasive acral melanoma. Cancer Cell. 2024;42:1067\u2013e10851011. https:\/\/doi.org\/10.1016\/j.ccell.2024.04.012","journal-title":"Cancer Cell"},{"key":"3516_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.semcancer.2019.10.017","volume":"61","author":"YA Chen","year":"2020","unstructured":"Chen YA, et al. Translational pathology, genomics and the development of systemic therapies for acral melanoma. Sem Cancer Biol. 2020;61:149\u201357. https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.017","journal-title":"Sem Cancer Biol"},{"key":"3516_CR5","doi-asserted-by":"publisher","first-page":"8119","DOI":"10.1038\/s41467-023-43980-y","volume":"14","author":"C Wei","year":"2023","unstructured":"Wei C, et al. Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses. Nat Commun. 2023;14:8119. https:\/\/doi.org\/10.1038\/s41467-023-43980-y","journal-title":"Nat Commun"},{"key":"3516_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.annonc.2020.05.031","volume":"31","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, et al. Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients. Ann Oncol. 2020;31:1198\u2013206. https:\/\/doi.org\/10.1016\/j.annonc.2020.05.031","journal-title":"Ann Oncol"},{"key":"3516_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/path.5213","volume":"247","author":"R Rabbie","year":"2019","unstructured":"Rabbie R, Ferguson P, Molina-Aguilar C, Adams DJ, Robles-Espinoza CD. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. J Pathol. 2019;247:539\u201351. https:\/\/doi.org\/10.1002\/path.5213","journal-title":"J Pathol"},{"key":"3516_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41586-022-05242-7","volume":"610","author":"P Karras","year":"2022","unstructured":"Karras P, et al. A cellular hierarchy in melanoma uncouples growth and metastasis. Nature. 2022;610:190\u20138. https:\/\/doi.org\/10.1038\/s41586-022-05242-7","journal-title":"Nature"},{"key":"3516_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","volume":"187","author":"J Pozniak","year":"2024","unstructured":"Pozniak J, et al. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma. Cell. 2024;187:166\u2013e183125. https:\/\/doi.org\/10.1016\/j.cell.2023.11.037","journal-title":"Cell"},{"key":"3516_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41421-024-00683-y","volume":"10","author":"H Shi","year":"2024","unstructured":"Shi H, et al. Single-cell sequencing depicts tumor architecture and empowers clinical decision in metastatic conjunctival melanoma. Cell Discovery. 2024;10:63. https:\/\/doi.org\/10.1038\/s41421-024-00683-y","journal-title":"Cell Discovery"},{"key":"3516_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/s41379-020-0500-9","volume":"33","author":"MG Niebling","year":"2020","unstructured":"Niebling MG, et al. The prognostic significance of microsatellites in cutaneous melanoma. Mod Pathol. 2020;33:1369\u201379. https:\/\/doi.org\/10.1038\/s41379-020-0500-9","journal-title":"Mod Pathol"},{"key":"3516_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/jnci\/djaa008","volume":"112","author":"S Bajaj","year":"2020","unstructured":"Bajaj S, et al. Melanoma prognosis: accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition. J Natl Cancer Inst. 2020;112:921\u20138. https:\/\/doi.org\/10.1093\/jnci\/djaa008","journal-title":"J Natl Cancer Inst"},{"key":"3516_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J Clin. 2017;67:472\u201392. https:\/\/doi.org\/10.3322\/caac.21409","journal-title":"CA Cancer J Clin"},{"key":"3516_CR14","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1245\/s10434-009-0350-7","volume":"16","author":"TF Kimsey","year":"2009","unstructured":"Kimsey TF, Cohen T, Patel A, Busam KJ, Brady MS. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol. 2009;16:1176\u201383. https:\/\/doi.org\/10.1245\/s10434-009-0350-7","journal-title":"Ann Surg Oncol"},{"key":"3516_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00000658-198412000-00015","volume":"200","author":"JW Kelly","year":"1984","unstructured":"Kelly JW, et al. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg. 1984;200:759\u201363. https:\/\/doi.org\/10.1097\/00000658-198412000-00015","journal-title":"Ann Surg"},{"key":"3516_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"CK Lee","year":"2019","unstructured":"Lee CK, et al. Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science. 2019;363:644\u20139. https:\/\/doi.org\/10.1126\/science.aav0173","journal-title":"Science"},{"key":"3516_CR17","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"YH Hao","year":"2021","unstructured":"Hao YH, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u2013+. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048","journal-title":"Cell"},{"key":"3516_CR18","doi-asserted-by":"publisher","unstructured":"Stuart T et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888\u20131902 e1821. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"3516_CR19","doi-asserted-by":"publisher","unstructured":"Puram SV et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171:1611\u20131624 e1624. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044","DOI":"10.1016\/j.cell.2017.10.044"},{"key":"3516_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9","journal-title":"Nat Commun"},{"key":"3516_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaad.2022.10.027","volume":"88","author":"R-M Loughlin","year":"2023","unstructured":"Loughlin R-M. Prognostic role of microsatellites in melanoma and implications in the American Joint Committee on Cancer Classification System: a cohort study. J Am Acad Dermatol. 2023;88:338\u201347. https:\/\/doi.org\/10.1016\/j.jaad.2022.10.027","journal-title":"J Am Acad Dermatol"},{"key":"3516_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396\u2013401. https:\/\/doi.org\/10.1126\/science.1254257","journal-title":"Science"},{"key":"3516_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-020-01264-9","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma X, et al. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Mol Cancer. 2020;19:147. https:\/\/doi.org\/10.1186\/s12943-020-01264-9","journal-title":"Mol Cancer"},{"key":"3516_CR24","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1158\/0008-5472.Can-06-3481","volume":"67","author":"SR Alonso","year":"2007","unstructured":"Alonso SR, et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007;67:3450\u201360. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-3481","journal-title":"Cancer Res"},{"key":"3516_CR25","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pi\u00f1ero","year":"2017","unstructured":"Pi\u00f1ero J, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45:D833\u20139. https:\/\/doi.org\/10.1093\/nar\/gkw943","journal-title":"Nucleic Acids Res"},{"key":"3516_CR26","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41467-022-28801-y","volume":"13","author":"C Capparelli","year":"2022","unstructured":"Capparelli C, et al. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma. Nat Commun. 2022;13:1381. https:\/\/doi.org\/10.1038\/s41467-022-28801-y","journal-title":"Nat Commun"},{"key":"3516_CR27","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.jid.2017.06.026","volume":"137","author":"W Dai","year":"2017","unstructured":"Dai W, et al. SOX4 promotes proliferative signals by regulating glycolysis through AKT activation in melanoma cells. J Invest Dermatol. 2017;137:2407\u201316. https:\/\/doi.org\/10.1016\/j.jid.2017.06.026","journal-title":"J Invest Dermatol"},{"key":"3516_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1755-148X.2010.00711.x","volume":"23","author":"ML Harris","year":"2010","unstructured":"Harris ML, Baxter LL, Loftus SK, Pavan WJ. Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010;23:496\u2013513. https:\/\/doi.org\/10.1111\/j.1755-148X.2010.00711.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"3516_CR29","doi-asserted-by":"publisher","first-page":"106919","DOI":"10.1016\/j.isci.2023.106919","volume":"26","author":"I Stufchen","year":"2023","unstructured":"Stufchen I, et al. Sox9 regulates melanocytic fate decision of adult hair follicle stem cells. iScience. 2023;26:106919. https:\/\/doi.org\/10.1016\/j.isci.2023.106919","journal-title":"iScience"},{"key":"3516_CR30","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1038\/s41467-024-51995-2","volume":"15","author":"I Godet","year":"2024","unstructured":"Godet I, et al. Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-C. Nat Commun. 2024;15:8416. https:\/\/doi.org\/10.1038\/s41467-024-51995-2","journal-title":"Nat Commun"},{"key":"3516_CR31","doi-asserted-by":"publisher","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology. 2020;161. https:\/\/doi.org\/10.1210\/endocr\/bqz046","DOI":"10.1210\/endocr\/bqz046"},{"key":"3516_CR32","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.bbamem.2011.07.026","volume":"1808","author":"S Riedl","year":"2011","unstructured":"Riedl S, et al. In search of a novel target \u2014 phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim Et Biophys Acta (BBA) - Biomembr. 2011;1808:2638\u201345. https:\/\/doi.org\/10.1016\/j.bbamem.2011.07.026","journal-title":"Biochim Et Biophys Acta (BBA) - Biomembr"},{"key":"3516_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7:376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9","journal-title":"Signal Transduct Target Ther"},{"key":"3516_CR34","doi-asserted-by":"publisher","first-page":"ARTNeadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, et al. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16:ARTNeadg3840. https:\/\/doi.org\/10.1126\/scitranslmed.adg3840","journal-title":"Sci Transl Med"},{"key":"3516_CR35","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby D, et al. Early detection of cancer. Science. 2022;375:eaay9040. https:\/\/doi.org\/10.1126\/science.aay9040","journal-title":"Science"},{"key":"3516_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12094-012-0804-4","volume":"14","author":"E Espinosa","year":"2012","unstructured":"Espinosa E, et al. Advances in cutaneous melanoma. Clin Transl Oncol. 2012;14:325\u201332. https:\/\/doi.org\/10.1007\/s12094-012-0804-4","journal-title":"Clin Transl Oncol"},{"key":"3516_CR37","doi-asserted-by":"publisher","unstructured":"Kasakovski D, Skrygan M, Gambichler T, Susok L. Advances in targeting cutaneous melanoma. Cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/cancers13092090","DOI":"10.3390\/cancers13092090"},{"key":"3516_CR38","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-21-3145","volume":"28","author":"J Li","year":"2022","unstructured":"Li J, et al. Single-cell characterization of the cellular landscape of acral melanoma identifies novel targets for immunotherapy. Clin Cancer Res. 2022;28:2131\u201346. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3145","journal-title":"Clin Cancer Res"},{"key":"3516_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, et al. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther. 2024;9:128. https:\/\/doi.org\/10.1038\/s41392-024-01828-x","journal-title":"Signal Transduct Target Ther"},{"key":"3516_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11864-022-00940-w","volume":"23","author":"H Hashimoto","year":"2022","unstructured":"Hashimoto H, Tanaka Y, Murata M, Ito T. Nectin-4: a novel therapeutic target for skin cancers. Curr Treat Options Oncol. 2022;23:578\u201393. https:\/\/doi.org\/10.1007\/s11864-022-00940-w","journal-title":"Curr Treat Options Oncol"},{"key":"3516_CR41","doi-asserted-by":"publisher","unstructured":"Wang H et al. Targeting Wnt\/beta-catenin signaling exacerbates ferroptosis and increases the efficacy of melanoma immunotherapy via the regulation of MITF. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11223580","DOI":"10.3390\/cells11223580"},{"key":"3516_CR42","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1038\/s41598-019-39926-4","volume":"9","author":"G Barbarani","year":"2019","unstructured":"Barbarani G, Fugazza C, Barabino SML, Ronchi AE. SOX6 blocks the proliferation of BCR-ABL1(+) and JAK2V617F(+) leukemic cells. Sci Rep. 2019;9:3388. https:\/\/doi.org\/10.1038\/s41598-019-39926-4","journal-title":"Sci Rep"},{"key":"3516_CR43","doi-asserted-by":"publisher","first-page":"1783081","DOI":"10.1080\/23723556.2020.1783081","volume":"7","author":"A Marchetto","year":"2020","unstructured":"Marchetto A, Grunewald TGP. SOX6: a double-edged sword for ewing sarcoma. Mol Cell Oncol. 2020;7:1783081. https:\/\/doi.org\/10.1080\/23723556.2020.1783081","journal-title":"Mol Cell Oncol"},{"key":"3516_CR44","doi-asserted-by":"publisher","first-page":"10287","DOI":"10.1038\/s41598-024-60438-3","volume":"14","author":"V Pastori","year":"2024","unstructured":"Pastori V, et al. Transcriptional repression of the oncofetal LIN28B gene by the transcription factor SOX6. Sci Rep. 2024;14:10287. https:\/\/doi.org\/10.1038\/s41598-024-60438-3","journal-title":"Sci Rep"},{"key":"3516_CR45","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1186\/s13018-023-04399-9","volume":"18","author":"S Long","year":"2023","unstructured":"Long S, et al. Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6. J Orthop Surg Res. 2023;18:937. https:\/\/doi.org\/10.1186\/s13018-023-04399-9","journal-title":"J Orthop Surg Res"},{"key":"3516_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/CAD.0000000000001004","volume":"32","author":"L Zhang","year":"2021","unstructured":"Zhang L, et al. SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer. Anticancer Drugs. 2021;32:306\u201313. https:\/\/doi.org\/10.1097\/CAD.0000000000001004","journal-title":"Anticancer Drugs"},{"key":"3516_CR47","doi-asserted-by":"publisher","first-page":"114764","DOI":"10.1016\/j.celrep.2024.114764","volume":"43","author":"BJ Woo","year":"2024","unstructured":"Woo BJ, et al. Integrative identification of non-coding regulatory regions driving metastatic prostate cancer. Cell Rep. 2024;43:114764. https:\/\/doi.org\/10.1016\/j.celrep.2024.114764","journal-title":"Cell Rep"},{"key":"3516_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-022-04892-9","volume":"13","author":"J Ji","year":"2022","unstructured":"Ji J, et al. FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development. Cell Death Dis. 2022;13:442. https:\/\/doi.org\/10.1038\/s41419-022-04892-9","journal-title":"Cell Death Dis"},{"key":"3516_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biocel.2019.01.014","volume":"109","author":"M Lin","year":"2019","unstructured":"Lin M, et al. UBE2S mediates tumor progression via SOX6\/beta-Catenin signaling in endometrial cancer. Int J Biochem Cell Biol. 2019;109:17\u201322. https:\/\/doi.org\/10.1016\/j.biocel.2019.01.014","journal-title":"Int J Biochem Cell Biol"},{"key":"3516_CR50","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.7150\/ijbs.69802","volume":"18","author":"J Quan","year":"2022","unstructured":"Quan J, et al. Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGF\u03b21-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma. Int J Biol Sci. 2022;18:2484\u201396. https:\/\/doi.org\/10.7150\/ijbs.69802","journal-title":"Int J Biol Sci"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T03:49:19Z","timestamp":1756266559000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3516"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03516-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shanghai Changhai Hostpital Ethics Committee. All participants provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declared all authors have approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}